United Therapeutics (UTHR) Current Deferred Tax Assets (2009 - 2013)

United Therapeutics has reported Current Deferred Tax Assets for 5 years, with the latest figure at $14.6 million in Q2 2013.

• Quarterly Current Deferred Tax Assets rose 77.51% year-over-year to $14.6 million in Q2 2013, while the trailing twelve-month figure through Jun 2013 was $14.6 million (up 77.51% YoY) and the FY2012 annual result came in at $14.6 million, up 77.51% from the prior year.
• Current Deferred Tax Assets steadied at $14.6 million in Q2 2013 per UTHR's latest filing, from $14.6 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $14.6 million in Q4 2012 and troughed at $2.3 million in Q1 2011.
• A 5-year average of $9.0 million and a median of $8.2 million in 2011 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2011 and 2012: Current Deferred Tax Assets sank 80.39% in 2011, then jumped 255.09% in 2012.
• Over 5 years, Current Deferred Tax Assets stood at $7.2 million in 2009, then surged by 74.99% to $12.6 million in 2010, then tumbled by 34.85% to $8.2 million in 2011, then surged by 77.51% to $14.6 million in 2012, then changed by 0.0% to $14.6 million in 2013.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $14.6 million, $14.6 million, and $14.6 million for Q2 2013, Q1 2013, and Q4 2012 respectively.